Dimitris Voliotis Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

ZNTL Quotes by TradingView

Dimitris Voliotis is SVP, Clinical Development of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 15,978 shares of ZNTL, which is worth approximately $50,810. The most recent transaction as insider was on Feb 14, 2022, when has been sold 601 shares (Common Stock) at a price of $50.46 per share, resulting in proceeds of $30,326. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16K
0% 3M change
0% 12M change
Total Value Held $50,810

Dimitris Voliotis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2022
SELL
Open market or private sale
$30,326 $50.46 p/Share
601 Reduced 3.63%
15,978 Common Stock
Feb 10 2022
BUY
Grant, award, or other acquisition
-
10,329 Added 38.39%
16,579 Common Stock
Jan 20 2022
SELL
Open market or private sale
$608,700 $60.87 p/Share
10,000 Reduced 61.54%
6,250 Common Stock
Jan 20 2022
BUY
Exercise of conversion of derivative security
$180,000 $18.0 p/Share
10,000 Added 38.1%
16,250 Common Stock
Jan 19 2022
SELL
Open market or private sale
$614,300 $61.43 p/Share
10,000 Reduced 61.54%
6,250 Common Stock
Jan 19 2022
BUY
Exercise of conversion of derivative security
$180,000 $18.0 p/Share
10,000 Added 38.1%
16,250 Common Stock
Jan 18 2022
SELL
Open market or private sale
$630,500 $63.05 p/Share
10,000 Reduced 61.54%
6,250 Common Stock
Jan 18 2022
BUY
Exercise of conversion of derivative security
$180,000 $18.0 p/Share
10,000 Added 38.1%
16,250 Common Stock
Feb 11 2021
BUY
Grant, award, or other acquisition
-
6,250 Added 50.0%
6,250 Common Stock
DV

Dimitris Voliotis

SVP, Clinical Development
New York, NY

Track Institutional and Insider Activities on ZNTL

Follow Zentalis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZNTL shares.

Notify only if

Insider Trading

Get notified when an Zentalis Pharmaceuticals, Inc. insider buys or sells ZNTL shares.

Notify only if

News

Receive news related to Zentalis Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ZNTL